Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms.
Frenken
L G
LG
Biotechnology Group, Unilever Research Vlaardingen, The Netherlands.
Hessing
J G
JG
Van den Hondel
C A
CA
Verrips
C T
CT
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D001230:Aspergillus / Q000235:genetics / Q000378:metabolism; D001709:Biotechnology; D005285:Fermentation; D005658:Fungi / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000096:biosynthesis* / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism
D000911:Antibodies, Monoclonal; D007128:Immunoglobulin Fragments; D011993:Recombinant Fusion Proteins